
Expert Interviews
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Igalmi for at-home use for agitation in schizophrenia and bipolar disorder
2
White House pulls Overton FDA nomination, Marshall might be nominated instead
3
More antigen on a cancer vaccine meant more tumor-fighting T cells in mice
4
Quick Q&A: Benjamin N. Rome, M.D., M.P.H., on the IRA and drug launch prices
5

